- All > Medicine Information and Evidence for Policy > Medicines Policy
- All > Medicine Access and Rational Use > Financing
(2014; 27 pages)
This case study examines the pharmaceutical management policies of the Jamkesmas health insurance scheme which is directed at the poor and near-poor population of Indonesia. With over 76 million beneficiaries in 2012, the Jamkesmas program is the largest health insurance scheme in Indonesia covering one-third of the nation’s population. The pharmaceutical policies within this insurance scheme will serve as an important case study of how Indonesia promotes cost-effective use of medicine.